BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,087,408 | -1.6% | 1,120,000 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $1,104,578 | -4.0% | 1,120,000 | 0.0% | 0.02% | -15.4% |
| Q1 2023 | $1,150,498 | -83.4% | 1,120,000 | -83.5% | 0.03% | -86.9% |
| Q2 2018 | $6,913,000 | +8.1% | 6,800,000 | 0.0% | 0.20% | +6.5% |
| Q1 2018 | $6,395,000 | -5.9% | 6,800,000 | 0.0% | 0.19% | -4.6% |
| Q4 2017 | $6,794,000 | -14.3% | 6,800,000 | -12.8% | 0.20% | -13.7% |
| Q3 2017 | $7,924,000 | – | 7,800,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |